What truly drives hormonal chaos at the molecular level? That’s the enduring question at the heart of the work conducted by endocrine pathophysiologists. Rather than focusing solely on symptoms or organ-level dysfunction, these experts investigate the intricate signaling failures, receptor abnormalities, and transcriptional disruptions that underlie endocrine disorders. From cortisol resistance to rare genetic defects in thyroid hormone synthesis, their lens is tuned to the cellular dialogues that determine health or disease. Their insights are central to refining our understanding of how metabolic, reproductive, and developmental pathways become disrupted—and how targeted therapies can restore physiological balance.
In recent years, endocrine pathophysiologists have contributed significantly to the identification of novel biomarkers and hormone receptor mutations, reshaping diagnostic frameworks for conditions like insulinoma, Cushing’s syndrome, and congenital adrenal hyperplasia. They often collaborate across specialties, supporting translational projects that bridge laboratory discoveries with clinical interventions. Their work also informs the design of hormone replacement therapies, endocrine disruptor risk assessments, and next-generation diagnostics using proteomic and metabolomic profiling. By mapping endocrine dysfunction at its source, they not only advance precision medicine but also help shift treatment paradigms away from symptom control and toward mechanism-based correction—a direction that holds immense promise for endocrinology as a whole.










Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences